These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 1857411)

  • 1. Anti-HIV drug mechanism.
    Jones IM; Jacob GS
    Nature; 1991 Jul; 352(6332):198. PubMed ID: 1857411
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of N-(3-phenyl-2-propenyl)-1-deoxynojirimycin on the lectin binding to HIV-1 glycoproteins.
    Shimizu H; Tsuchie H; Honma H; Yoshida K; Tsuruoka T; Ushijima H; Kitamura T
    Jpn J Med Sci Biol; 1990 Jun; 43(3):75-87. PubMed ID: 2283726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interference with HIV-induced syncytium formation and viral infectivity by inhibitors of trimming glucosidase.
    Gruters RA; Neefjes JJ; Tersmette M; de Goede RE; Tulp A; Huisman HG; Miedema F; Ploegh HL
    Nature; 1987 Nov 5-11; 330(6143):74-7. PubMed ID: 2959866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental treatments for HIV-infected patients.
    Am Fam Physician; 1989 Jun; 39(6):330. PubMed ID: 2729046
    [No Abstract]   [Full Text] [Related]  

  • 5. Boromycin, an anti-HIV antibiotic.
    Kohno J; Kawahata T; Otake T; Morimoto M; Mori H; Ueba N; Nishio M; Kinumaki A; Komatsubara S; Kawashima K
    Biosci Biotechnol Biochem; 1996 Jun; 60(6):1036-7. PubMed ID: 8695905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of HIV and SIV infectivity by blockade of alpha-glucosidase activity.
    Ratner L; vander Heyden N; Dedera D
    Virology; 1991 Mar; 181(1):180-92. PubMed ID: 1704656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of novel 1-deoxynojirimycin derivatives on HIV-1 replication.
    Shimizu H; Tsuchie H; Yoshida K; Morikawa S; Tsuruoka T; Yamamoto H; Ushijima H; Kitamura T
    AIDS; 1990 Oct; 4(10):975-9. PubMed ID: 2148090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of glycolipid analogues that disrupt binding of HIV-1 gp120 to galactosylceramide.
    Weber KT; Hammache D; Fantini J; Ganem B
    Bioorg Med Chem Lett; 2000 May; 10(10):1011-4. PubMed ID: 10843204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of gp120 binding to galactosyl ceramide and sulfatide by potential anti-HIV compounds.
    Bhat S; Otsuka T; Srinivasan A
    AIDS; 1992 Oct; 6(10):1213-4. PubMed ID: 1466855
    [No Abstract]   [Full Text] [Related]  

  • 10. Interaction of an anti-HIV peptide, T22, with gp120 and CD4.
    Tamamura H; Otaka A; Murakami T; Ishihara T; Ibuka T; Waki M; Matsumoto A; Yamamoto N; Fujii N
    Biochem Biophys Res Commun; 1996 Feb; 219(2):555-9. PubMed ID: 8605026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What's in the works.
    Horn T
    Posit Living; 2001 Feb; 10(2):20-2. PubMed ID: 11548496
    [No Abstract]   [Full Text] [Related]  

  • 12. Actinohivin, a novel anti-human immunodeficiency virus protein from an actinomycete, inhibits viral entry to cells by binding high-mannose type sugar chains of gp120.
    Chiba H; Inokoshi J; Nakashima H; Omura S; Tanaka H
    Biochem Biophys Res Commun; 2004 Mar; 316(1):203-10. PubMed ID: 15003531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of a focal infectivity assay for testing susceptibility of HIV to antiviral agents.
    Pincus SH; Wehrly K; Chesebro B
    Biotechniques; 1991 Mar; 10(3):336-42. PubMed ID: 2064772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constituents of Ardisia japonica and their in vitro anti-HIV activity.
    Piacente S; Pizza C; De Tommasi N; Mahmood N
    J Nat Prod; 1996 Jun; 59(6):565-9. PubMed ID: 8786362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulphated polysaccharides exert anti-HIV activity at differing sites.
    Harrop HA; Rider CC; Coombe DR
    Biochem Soc Trans; 1992 May; 20(2):163S. PubMed ID: 1397551
    [No Abstract]   [Full Text] [Related]  

  • 16. Structural requirements for and consequences of an antiviral porphyrin binding to the V3 loop of the human immunodeficiency virus (HIV-1) envelope glycoprotein gp120.
    Neurath AR; Strick N; Debnath AK
    J Mol Recognit; 1995; 8(6):345-57. PubMed ID: 9052975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycophenolic acid inhibits syncytium formation accompanied by reduction of gp120 expression.
    Ui H; Asanuma S; Chiba H; Takahashi A; Yamaguchi Y; Masuma R; Omura S; Tanaka H
    J Antibiot (Tokyo); 2005 Aug; 58(8):514-8. PubMed ID: 16266123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Glycosidase inhibitors as anti-HIV agents].
    Nishimura Y
    Nihon Rinsho; 1993 Sep; 51 Suppl():180-5. PubMed ID: 8271382
    [No Abstract]   [Full Text] [Related]  

  • 19. Multiple and multivalent interactions of novel anti-AIDS drug candidates, sulfated polymannuronate (SPMG)-derived oligosaccharides, with gp120 and their anti-HIV activities.
    Liu H; Geng M; Xin X; Li F; Zhang Z; Li J; Ding J
    Glycobiology; 2005 May; 15(5):501-10. PubMed ID: 15616125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flavonoid baicalin inhibits HIV-1 infection at the level of viral entry.
    Li BQ; Fu T; Dongyan Y; Mikovits JA; Ruscetti FW; Wang JM
    Biochem Biophys Res Commun; 2000 Sep; 276(2):534-8. PubMed ID: 11027509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.